表紙
市場調查報告書

中樞神經系統醫藥品的全球市場:止痛藥·抗帕金森藥·麻醉劑·抗癲癇藥·其他

Central Nervous System Drugs Global Market Report 2019

出版商 The Business Research Company 商品編碼 531325
出版日期 內容資訊 英文 300 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中樞神經系統醫藥品的全球市場:止痛藥·抗帕金森藥·麻醉劑·抗癲癇藥·其他 Central Nervous System Drugs Global Market Report 2019
出版日期: 2019年01月01日內容資訊: 英文 300 Pages
簡介

本報告提供全球中樞神經系統醫藥品的市場調查,提供市場定義和概要,市場的各種影響因素分析,各藥物部門·各地各國趨勢與市場規模的變化與預測,並彙整與宏觀經濟因素·醫療保健市場全體·各種產業指標的比較,競爭環境,企業簡介等資料。

第1章 市場特徵

第2章 市場規模·成長率

  • 市場成長:迄今的過程
    • 成長推進因素
    • 阻礙成長要素
  • 市場成長:預測
    • 成長推進因素
    • 阻礙成長要素

第3章 大環境分析

第4章 客戶資訊

第5章 中樞神經系統醫藥品市場分析:各種類

  • 全球市場的實際成果:各種類
    • 止痛藥
    • 抗帕金森藥
    • 麻醉劑
    • 抗癲癇藥
    • 其他
  • 全球市場的變化與預測:各種類
  • 市場趨勢·策略

第6章 中樞神經系統醫藥品市場分析:各地各國分析

  • 全球市場的實際成果:各地區
  • 全球市場的變化與預測:各地區
  • 市場實際成果:各國
  • 市場變化與預測:各國
  • 全球醫藥品市場實際成果:部門·各地區
  • 全球醫藥品市場實際成果:部門·各國

第7章 宏觀經濟因素與市場比較

  • 市場規模的佔 GDP的百分比
  • 平均每個人的平均支出額

第8章 宏觀經濟因素與市場比較:各國

  • 市場規模的佔 GDP的百分比:各國
  • 平均每個人的平均支出額:各國

第9章 產業指標與市場比較

  • 全球藥劑師數:各國
  • 市場收益 vs 藥劑師數:各國
  • 全球醫藥品公司數:各國
  • 市場收益 vs 醫藥品公司數:各國
  • 全球對R&D/產品開發的平均支出額:各國
  • 市場收益 vs 對R&D/產品開發的平均支出額:各國
  • 全球非專利&品牌銷售額的比例:各國
  • 市場收益 vs 非專利&品牌銷售額的比例:各國
  • 帕金森氏症的患病人數:各國
  • 全球精神科醫生數:各國
  • 市場收益 vs 精神科醫生數:各國
  • 全球一般開業醫生數:各國
  • 市場收益 vs 一般開業醫生數:各國

第10章 亞太地區市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 中國
  • 印度
  • 日本
  • 澳洲

第11章 西歐市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙

第12章 東歐市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 俄羅斯

第13章 北美市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 美國

第14章 南美市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 巴西

第15章 中東市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類

第16章 非洲市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類

第17章 競爭環境

  • 企業簡介
  • Pfizer Inc.
  • Biogen Idec
  • Novartis Ag
  • 大塚製藥
  • Teva 醫藥品

第18章 主要M&A:中樞神經系統醫藥品市場

第19章 市場背景:醫藥品市場

第20章 醫藥品產業的Financial Margins

第21章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Central Nervous System Drugs Market Global Report 2019 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global central nervous system drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the central nervous system drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Central Nervous System Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The central nervous system drugs market section of the report gives context. It compares the central nervous system drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, central nervous system drugs indicators comparison.

Scope

Markets Covered: Nervous System Drugs, Analgesics, Anti-Parkinson drugs, Anesthetics, Anti-Epileptics, Other CNS drugs

Companies Mentioned: Biogen Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Pfizer Inc, Novartis AG

Metrics Covered: Parkinson Prevalence Rate, Number of Enterprises, Number of Employees

Countries: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, central nervous system drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Central Nervous System Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Central Nervous System Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Central Nervous System Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Central Nervous System Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Central Nervous System Drugs Market Trends And Strategies

8. Central Nervous System Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Central Nervous System Drugs Market Regional Analysis

  • 9.1. Global Central Nervous System Drugs Market, 2018, By Region, Value ($ Billion)
  • 9.2. Global Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 9.3. Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region

10. Central Nervous System Drugs Market Segmentation

  • 10.1. Global Central Nervous System Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
    • 10.1.1. Nervous System Drugs
    • 10.1.2. Analgesics
    • 10.1.3. Anti-Parkinson drugs
    • 10.1.4. Anesthetics
    • 10.1.5. Anti-Epileptics
    • 10.1.6. Other CNS drugs

11. Central Nervous System Drugs Market Metrics

  • 11.1. Central Nervous System Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
  • 11.2. Per Capita Average Central Nervous System Drugs Market Expenditure, 2014 - 2022, Global

12. Asia-Pacific Central Nervous System Drugs Market

  • 12.1. Asia-Pacific Central Nervous System Drugs Market Overview
  • 12.2. Asia-Pacific, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Central Nervous System Drugs Market Metrics
    • 12.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries
    • 12.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Asia-Pacific Countries
  • 12.6. Asia-Pacific Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 12.7. Asia-Pacific Central Nervous System Drugs Market: Country Analysis
    • 12.7.1. China Central Nervous System Drugs Market
      • 12.7.1.1. China Central Nervous System Drugs Market Overview
      • 12.7.1.2. China Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.1.3. China Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.1.4. China Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.2. Australia Central Nervous System Drugs Market
      • 12.7.2.1. Australia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.2.2. Australia Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.2.3. Australia Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.3. Hong Kong Central Nervous System Drugs Market
      • 12.7.3.1. Hong Kong Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.4. India Central Nervous System Drugs Market
      • 12.7.4.1. India Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.4.2. India Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.4.3. India Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.5. Indonesia Central Nervous System Drugs Market
      • 12.7.5.1. Indonesia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.6. Japan Central Nervous System Drugs Market
      • 12.7.6.1. Japan Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.6.2. Japan Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.6.3. Japan Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.7. Malaysia Central Nervous System Drugs Market
      • 12.7.7.1. Malaysia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.8. New Zealand Central Nervous System Drugs Market
      • 12.7.8.1. New Zealand Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.9. Philippines Central Nervous System Drugs Market
      • 12.7.9.1. Philippines Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.10. Singapore Central Nervous System Drugs Market
      • 12.7.10.1. Singapore Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.11. South Korea Central Nervous System Drugs Market
      • 12.7.11.1. South Korea Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.12. Thailand Central Nervous System Drugs Market
      • 12.7.12.1. Thailand Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.13. Vietnam Central Nervous System Drugs Market
      • 12.7.13.1. Vietnam Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)

13. Western Europe Central Nervous System Drugs Market

  • 13.1. Western Europe Central Nervous System Drugs Market Overview
  • 13.2. Western Europe, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 13.3. Western Europe, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 13.4. Western Europe, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Central Nervous System Drugs Market Metrics
    • 13.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Western Europe Countries
    • 13.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Western Europe Countries
  • 13.6. Western Europe Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 13.7. Western Europe Central Nervous System Drugs Market: Country Analysis
    • 13.7.1. Austria Central Nervous System Drugs Market
      • 13.7.1.1. Austria Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.2. Belgium Central Nervous System Drugs Market
      • 13.7.2.1. Belgium Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.3. Denmark Central Nervous System Drugs Market
      • 13.7.3.1. Denmark Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.4. Finland Central Nervous System Drugs Market
      • 13.7.4.1. Finland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.5. France Central Nervous System Drugs Market
      • 13.7.5.1. France Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.5.2. France Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.5.3. France Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.6. Germany Central Nervous System Drugs Market
      • 13.7.6.1. Germany Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.6.2. Germany Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.6.3. Germany Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.7. Ireland Central Nervous System Drugs Market
      • 13.7.7.1. Ireland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.8. Italy Central Nervous System Drugs Market
      • 13.7.8.1. Italy Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.8.2. Italy Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.8.3. Italy Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.9. Netherlands Central Nervous System Drugs Market
      • 13.7.9.1. Netherlands Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.10. Norway Central Nervous System Drugs Market
      • 13.7.10.1. Norway Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.11. Portugal Central Nervous System Drugs Market
      • 13.7.11.1. Portugal Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.12. Spain Central Nervous System Drugs Market
      • 13.7.12.1. Spain Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.12.2. Spain Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.12.3. Spain Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.13. Sweden Central Nervous System Drugs Market
      • 13.7.13.1. Sweden Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.14. Switzerland Central Nervous System Drugs Market
      • 13.7.14.1. Switzerland Central Nervous System Drugs Market2013 - 2022, Value ($ Billion)
    • 13.7.15. UK Central Nervous System Drugs Market
      • 13.7.15.1. UK Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.15.2. UK Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.15.3. UK Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

14. Eastern Europe Central Nervous System Drugs Market

  • 14.1. Eastern Europe Central Nervous System Drugs Market Overview
  • 14.2. Eastern Europe, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Central Nervous System Drugs Market Metrics
    • 14.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Eastern Europe Countries
    • 14.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Eastern Europe Countries
  • 14.6. Eastern Europe Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 14.7. Eastern Europe Central Nervous System Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Central Nervous System Drugs Market,
      • 14.7.1.1. Czech Republic Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.2. Poland Central Nervous System Drugs Market
      • 14.7.2.1. Poland Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.3. Romania Central Nervous System Drugs Market
      • 14.7.3.1. Romania Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.4. Russia Central Nervous System Drugs Market
      • 14.7.4.1. Russia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 14.7.4.2. Russia Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 14.7.4.3. Russia Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

15. North America Central Nervous System Drugs Market

  • 15.1. North America Central Nervous System Drugs Market Overview
  • 15.2. North America, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 15.3. North America, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 15.4. North America, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 15.5. North America, Central Nervous System Drugs Market Metrics
    • 15.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, North America Countries
    • 15.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, North America Countries
  • 15.6. North America Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 15.7. North America Central Nervous System Drugs Market: Country Analysis
    • 15.7.1. Canada Central Nervous System Drugs Market
      • 15.7.1.1. Canada Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.2. Mexico Central Nervous System Drugs Market
      • 15.7.2.1. Mexico Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.3. USA Central Nervous System Drugs Market
      • 15.7.3.1. USA Central Nervous System Drugs Market Overview
      • 15.7.3.2. USA Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 15.7.3.3. USA Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 15.7.3.4. USA Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

16. South America Central Nervous System Drugs Market

  • 16.1. South America Central Nervous System Drugs Market Overview
  • 16.2. South America, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 16.3. South America, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 16.4. South America, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 16.5. South America, Central Nervous System Drugs Market Metrics
    • 16.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, South America Countries
    • 16.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, South America Countries
  • 16.6. South America Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 16.7. South America Central Nervous System Drugs Market: Country Analysis
    • 16.7.1. Argentina Central Nervous System Drugs Market
      • 16.7.1.1. Argentina Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.2. Brazil Central Nervous System Drugs Market
      • 16.7.2.1. Brazil Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
      • 16.7.2.2. Brazil Central Nervous System Drugs Market, 2014 - 2022, Volume (Million Units)
      • 16.7.2.3. Brazil Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 16.7.3. Chile Central Nervous System Drugs Market
      • 16.7.3.1. Chile Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.4. Colombia Central Nervous System Drugs Market
      • 16.7.4.1. Colombia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.5. Peru Central Nervous System Drugs Market
      • 16.7.5.1. Peru Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.6. Venezuela Central Nervous System Drugs Market
      • 16.7.6.1. Venezuela Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)

17. Middle East Central Nervous System Drugs Market

  • 17.1. Middle East Central Nervous System Drugs Market Overview
  • 17.2. Middle East, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 17.3. Middle East, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 17.4. Middle East, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Central Nervous System Drugs Market Metrics
    • 17.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Middle East Countries
    • 17.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Middle East Countries
  • 17.6. Middle East Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 17.7. Middle East Central Nervous System Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Central Nervous System Drugs Market
      • 17.7.1.1. Saudi Arabia Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.2. Israel Central Nervous System Drugs Market
      • 17.7.2.1. Israel Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.3. Turkey Central Nervous System Drugs Market
      • 17.7.3.1. Turkey Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.4. UAE Central Nervous System Drugs Market
      • 17.7.4.1. UAE Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)

18. Africa Central Nervous System Drugs Market

  • 18.1. Africa Central Nervous System Drugs Market Overview
  • 18.2. Africa, Central Nervous System Drugs Market, 2018, By Country, Value ($ Billion)
  • 18.3. Africa, Central Nervous System Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 18.4. Africa, Central Nervous System Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Central Nervous System Drugs Market Metrics
    • 18.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014 - 2022, Africa Countries
    • 18.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Africa Countries
  • 18.6. Africa Central Nervous System Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 18.7. Africa Central Nervous System Drugs Market: Country Analysis
    • 18.7.1. Egypt Central Nervous System Drugs Market
      • 18.7.1.1. Egypt Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.2. Nigeria Central Nervous System Drugs Market
      • 18.7.2.1. Nigeria Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.3. South Africa Central Nervous System Drugs Market
      • 18.7.3.1. South Africa Central Nervous System Drugs Market, 2014 - 2022, Value ($ Billion)

19. Central Nervous System Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. Biogen Inc
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Company Central Nervous System Drugs Market Structure And Strategy
      • 19.3.1.3. Company Central Nervous System Drugs Market Products And Services
      • 19.3.1.4. Financial Performance
    • 19.3.2. F. Hoffmann-La Roche Ltd
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Company Central Nervous System Drugs Market Structure And Strategy
      • 19.3.2.3. Company Central Nervous System Drugs Market Products And Services
      • 19.3.2.4. Financial Performance
    • 19.3.3. Johnson & Johnson
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Company Central Nervous System Drugs Market Structure And Strategy
      • 19.3.3.3. Company Central Nervous System Drugs Market Products And Services
      • 19.3.3.4. Financial Performance
    • 19.3.4. Pfizer Inc
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Company Central Nervous System Drugs Market Structure And Strategy
      • 19.3.4.3. Company Central Nervous System Drugs Market Products And Services
      • 19.3.4.4. Financial Performance
    • 19.3.5. Novartis AG
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Company Central Nervous System Drugs Market Structure And Strategy
      • 19.3.5.3. Company Central Nervous System Drugs Market Products And Services
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Central Nervous System Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022 Growth, by segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Central Nervous System Drugs Market In 2022- Growth Countries
  • 22.2. Global Central Nervous System Drugs Market In 2022- Growth Segments
  • 22.3. Global Central Nervous System Drugs Market In 2022- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer

Back to Top